Vitastem

12/19/2023

ViaDerma Eyes International Expansion for Vitastem Ultra into Large Healthcare Markets in Q1 2024

ViaDerma (OTC: VDRM), a highly innovative specialty pharmaceutical company based in Los Angeles, CA is making significant strides in their mission to revolutionize healthcare with their groundbreaking product, Vitastem Ultra. With a remarkable track record of treating & healing a plethora of infecti...

12/18/2023

Vitastem Ultra: This Potent Antibiotic is Transforming Diabetic Ulcer Treatments Unlike Anything Else in The Market

In the intricate landscape of diabetes, where the smallest wound can escalate into a major health crisis, diabetic ulcers stand as silent yet perilous adversaries to many millions of people around the world. These ulcers, often underestimated, pose severe health risks, complications, and can even be...

12/17/2023

Written in partnership with: Vitastem Ultra

12/14/2023

ViaDerma, a specialty pharmaceutical powerhouse, focuses on developing & licensing broad-spectrum antibiotics for infectious skin diseases and wound care.

12/04/2023

Vitastem Ultra, a new & innovative topical antibiotic spray that is 10x more effective at treating minor to severe wounds and many types of skin conditions.

11/21/2023

Vitastem Ultra: This Topical Antibiotic Can Help Reduce HAIs Costing Healthcare Upwards of $45 Billion Annually in The US Alone

It is paramount for healthcare institutions worldwide to consider the adoption of innovative solutions like Vitastem Ultra to alleviate the financial burden of HAIs and

11/06/2023

ViaDerma, Inc. has recently announced a series of new and noteworthy business developments that will undoubtedly pique the interest of current and potential

11/03/2023

One of the more promising wound treatments that is gaining a lot of popularity in the market today is Vitastem Ultra - a broad-spectrum topical antibiotic